Capella Science are thrilled to announce that FairJourney Biologics has selected the Sphere Fluidics Cyto-Mine® system to advance their cell line development workflows.
Cyto-Mine® is an automated platform which seamlessly integrates single cell screening, sorting, dispensing, imaging, and clone verification. Underpinned by its patented microfluidic picodroplet technology, it offers an intuitive interface and the capability to automatically screen up to 40 million cells within hours, a significant increase from the ~10,000 achieved through manual methods. This increased throughput is widely acknowledged in various research domains, including antibody discovery, cell line development, cell engineering, and synthetic biology. Furthermore, Cyto-Mine® enables swift, high-throughput single cell manipulation and analysis across emerging research areas such as precision genome editing, cell therapy research and cellular diagnostics.
Can the Sphere Fluidics Cyto-Mine® accelerate your workflow? Get in touch with Capella Science on (02) 9575 7512, firstname.lastname@example.org or Sphere Fluidics. FOR RESEARCH USE ONLY and not for use in diagnostic procedures.